• Date: November 14, 2017

Back in 1991, 14 November was the date set by the International Diabetes Federation and the World Health Organisation for World Diabetes Day. The event is the largest campaign of its kind to raise awareness of the metabolic disease, and reaches over 1 billion people worldwide.


One of the objectives of CaixaImpulse is to promote research transfer to the market in order to improve people’s health. Diabetes is a several complex condition affecting the quality of life of many people worldwide. In general, diabetes patients are to some extent unable to control the amount of sugar levels in their blood, and this is the focus of most treatments. However, this treatment results in some patients developing fatty liver disease.


Finding a new treatment for diabetic patients with associated fatty liver disease is one of the objectives of the APODRUG project. The project took part in CaixaImpulse in 2016, and is led by scientists from the Center for Applied Medical Research (CIMA) at the University of Navarra.

More programme highlights

December 13, 2018

Financing Week brings CaixaImpulse 2018 training to a close

The Financing Week marks the end of the training sessions for leaders of the projects chosen for this year's CaixaImpulse programme.

October 31, 2018

Penultimate week of training sessions for projects in CaixaImpulse 2018

From 6 to 9 November, the leaders of the projects selected to take part in CaixaImpulse 2018 have a date with the third week of training sessions offered under the programme.

October 11, 2018

The CaixaImpulse training programme continues with the Tech Transfer & Valorisation Week

Led by a number of different experts, this training focuses on product development and intellectual property.